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Introduction: 
Previous cross-sectional studies have reported lower ventilatory and aerobic function (peak 
oxygen uptake, VO2peak) during exercise in people with cystic fibrosis related diabetes (CFRD), 
compared to non-CFRD counterparts. Given that VO2peak is highly predictive of mortality, and 
the pancreas is one of the earliest affected organs in CF, there is a necessity to identify the 
interaction between exercise parameters and glycaemic status - particularly over time, which 
has implications for disease management in CFRD. 
 
Objectives: 
To examine differences in ventilatory and exercise-based changes (including VO2peak) in people 
with CF, of differing glycaemic status. 
 
Methods: 
Annual review data, including cardiopulmonary exercise testing and pulmonary function tests, 
were retrospectively analysed in n = 82 people with CF. Data was analysed in two ways: 1) 
three groups; normal glucose tolerance (NGT), impaired glucose tolerance (IGT) and CFRD, 
and 2) a dichotomous division of NGT versus a combined IGT + CFRD group. Data was 
analysed at baseline (T0) and one-year follow up (T1). Analysis of variance, with Bonferroni-




At baseline, absolute forced expiratory volume in one second (FEV1) and VO2peak were 
significantly reduced (p =0.01) in the CFRD (n = 19) group compared to NGT (n = 58). At T1, 
a reduced relative peak power (W.kg-1, p = 0.05), VO2peak (p = 0.03) and gas exchange threshold 
(p = 0.02) were observed from T0 in the combined group (n = 24) compared to the NGT group 
(n = 58). No change in VO2peak was identified over time, however, a significant decrease was 
discovered for FEV1 (%pred) in the NGT group between T0 and T1 (p = 0.02). 
 
Conclusions: 
Patients with CFRD have a reduced aerobic and ventilatory function compared to non-CFRD 
counterparts. Whilst a decrease in lung function was observed longitudinally, no change in 
VO2peak was found, thus alluding to how aerobic and ventilatory functions provide different 
clinical organ and systemic outcomes in CF. Future research building upon these findings 
should assist with future management strategies to increase the longevity and quality of life of 
those with CFRD. 
